We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Mtech Access - Powered by Petauri.
…
continue reading
تو این پادکست در مورد تکنولوژی، موفقیت، لایف استایل صحبت میکنیم. Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید. دوستون داریم Instagram : mtech.podcast Email : mtechpodcast@gmail.com امیر و علی
…
continue reading
1
Navigating US payer evidence needs to optimise market access
57:34
57:34
Spela senare
Spela senare
Listor
Gilla
Gillad
57:34
What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviews collea…
…
continue reading
1
Best practice RWE approaches to support economic modelling for HTA
59:53
59:53
Spela senare
Spela senare
Listor
Gilla
Gillad
59:53
How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison? Here, Mtech Access are joined by experts from Arcturis and Delta Hat. Dan Howard (Associate Director – Health Economics, Mtech Access) shares some…
…
continue reading
1
NHS winter planning 2024–25 – Engaging with NHS decision-makers through Autumn to Christmas
1:02:50
1:02:50
Spela senare
Spela senare
Listor
Gilla
Gillad
1:02:50
How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months? In August, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by Jo Turl (Former Director of Commissioning, Devon ICS) to explore…
…
continue reading
1
De-mystifying the NHS – What you need to know about the NHS as a market for your health technology
56:15
56:15
Spela senare
Spela senare
Listor
Gilla
Gillad
56:15
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a new health technology to the NHS in England? In July 2024, Global Whispers and NHS Whispers came together, to bring you an overarching view of what it takes to access the NHS wit…
…
continue reading
1
NHS primary care panel – the GP Contract and Operational Planning Guidance
1:02:14
1:02:14
Spela senare
Spela senare
Listor
Gilla
Gillad
1:02:14
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future of primary care? What are the biggest challenges facing primary care in 2024–25? In this webinar, Karen Cooper (Senior Consultant – NHS Insight & Interaction, Mtech Access) spoke to a…
…
continue reading
1
Engage NHS healthcare decision-makers with RWD
20:55
20:55
Spela senare
Spela senare
Listor
Gilla
Gillad
20:55
Discover how data visualisation dashboards can aid field teams in market access discussions with customers. Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted par…
…
continue reading
1
Market access and reimbursement in Canada – changes at CADTH
47:43
47:43
Spela senare
Spela senare
Listor
Gilla
Gillad
47:43
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ott…
…
continue reading
1
Rare Disease market access in the MENA and Nordic regions
59:10
59:10
Spela senare
Spela senare
Listor
Gilla
Gillad
59:10
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the EU4 and the US, but have you thought about other markets? Have you looked at the reimbursement requirements for rare disease products in the Nordic markets? Have you explored o…
…
continue reading
1
How does funding flow in NHSE Regions?
1:00:15
1:00:15
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:15
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with Region leaders? We sit down with guest speaker Richard Smale (Interim Director of System Co-ordination, NHS England [NHSE] – South West) for an all-encompassing discussion that explored fi…
…
continue reading
1
NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
1:02:06
1:02:06
Spela senare
Spela senare
Listor
Gilla
Gillad
1:02:06
What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation? Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mte…
…
continue reading
1
De-mystifying health economic model classifications and structures
1:00:28
1:00:28
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:28
What is health economic evaluation and which modelling approaches can be used to support market access activities? In this episode, our expert health economists explain the key strengths and limitations of the most common health economic modelling classifications and structures. Here, Hannah Gillies (Consultant – Health Economics) and Daniel MacDon…
…
continue reading
1
Evidence strategy for Medical Technologies and Diagnostics
53:24
53:24
Spela senare
Spela senare
Listor
Gilla
Gillad
53:24
Here, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or digital technology? Do you have the evidence required to support your value proposition? Would a health technology assessment (HTA) route be approp…
…
continue reading
1
How to set your Pharma or Medtech product up for success in the US market
43:06
43:06
Spela senare
Spela senare
Listor
Gilla
Gillad
43:06
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice commercialisation strategy for healthcare products launching in the US market. Clare Foy (Director – Global Market Access, Mtech Access) speaks to Janice MacLennan (…
…
continue reading
1
What's happening with specialised commissioning in the NHS?
1:00:08
1:00:08
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:08
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty? Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to expl…
…
continue reading
1
Integrated care in NHS Wales – what can England learn from its neighbour?
56:24
56:24
Spela senare
Spela senare
Listor
Gilla
Gillad
56:24
What does it take to run a truly patient-centric integrated health system? What does the Welsh journey with integration tell us about the future for England? Paul Mears (CEO, Cwm Taf Morgannwg University Health Board) joins Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) to explore the integrated care model in Wales and th…
…
continue reading
1
Market access in Italy: Reforms at AIFA
43:36
43:36
Spela senare
Spela senare
Listor
Gilla
Gillad
43:36
Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA). We explore: - The nature of the Ita…
…
continue reading
1
Unmet need in NHS primary care – How can industry best support PCN leaders?
1:00:44
1:00:44
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:44
Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond. Former ‘GP of the year’ and strategic influencer over prim…
…
continue reading
1
Population health management: a community effort across health and life sciences
1:04:01
1:04:01
Spela senare
Spela senare
Listor
Gilla
Gillad
1:04:01
How can our community support NHS leaders to deliver a data-led, people-centric health service? Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s popu…
…
continue reading
1
Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access
39:54
39:54
Spela senare
Spela senare
Listor
Gilla
Gillad
39:54
How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access? In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of op…
…
continue reading
1
6 areas of UK health policy for Medtech to pay attention to
1:01:49
1:01:49
Spela senare
Spela senare
Listor
Gilla
Gillad
1:01:49
How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators? Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for…
…
continue reading
1
Market access in the German speaking markets
57:59
57:59
Spela senare
Spela senare
Listor
Gilla
Gillad
57:59
Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets. Clare and Stefan discuss: …
…
continue reading
1
The role of nursing in driving digital change in the NHS
54:50
54:50
Spela senare
Spela senare
Listor
Gilla
Gillad
54:50
How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation? Prof. Phil Richardson (Chair and C…
…
continue reading
1
Market access for digital therapies and digital medicines
42:18
42:18
Spela senare
Spela senare
Listor
Gilla
Gillad
42:18
In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcome…
…
continue reading
1
A global market access journey in cannabinoid pharmaceuticals
53:47
53:47
Spela senare
Spela senare
Listor
Gilla
Gillad
53:47
What does it take to bring a cannabinoid pharmaceutical to market? We were delighted to welcome Michael Sassano (CEO – SOMAÍ Pharmaceuticals) as the first guest on our new Global Whispers webinar series. Michael shared with us his company’s experiences bringing new products to market, the challenges SOMAÍ Pharmaceuticals have faced and the lessons …
…
continue reading
1
Primary Care and ICBs – what is the next step in the integration journey?
1:01:17
1:01:17
Spela senare
Spela senare
Listor
Gilla
Gillad
1:01:17
How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows be impacted? Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Tim Goodson (Executive Officer, Dorset General Pract…
…
continue reading
1
(ChatGPT) - اپیزود ۱۶ - هوش مصنوعی و چت جی پی تی . ترفند های تغذیه و سلامتی روده
34:27
34:27
Spela senare
Spela senare
Listor
Gilla
Gillad
34:27
.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما, بهمون انرژی میده. پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید. Email : mtechpodcast@gmail.com
…
continue reading
1
Data-led transformation in the NHS - partnering to optimise patient care
1:02:35
1:02:35
Spela senare
Spela senare
Listor
Gilla
Gillad
1:02:35
Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner with the NHS to share data, transform services, and find smarter, faster way to improve patient care? Prof. Phil Richardson (Chair and Chief Innovation Officer, …
…
continue reading
1
Innovating for better health – research, collaboration and innovation in the NHS
57:56
57:56
Spela senare
Spela senare
Listor
Gilla
Gillad
57:56
How and where can innovation drive improvements in care and deliver better health for the population? How is the NHS looking to collaborate with key partners across industry and academia? What innovations are set to transform care? What role do Academic Health Science Networks (AHSNs) play and how can partners best engage with them? Prof Phil Richa…
…
continue reading
1
اپیزود پانزدهم - اعتماد به نفس - ۴ قدم مهم برای ساختن اعتماد به نفس
29:40
29:40
Spela senare
Spela senare
Listor
Gilla
Gillad
29:40
.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید.
…
continue reading
1
اپیزود چهاردهم - ۲۶ عادت برای افزایش تمرکز
26:58
26:58
Spela senare
Spela senare
Listor
Gilla
Gillad
26:58
.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید.
…
continue reading
1
Healthcare, economics and society – unlocking NHS collaboration
59:23
59:23
Spela senare
Spela senare
Listor
Gilla
Gillad
59:23
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits? Prof Phil Richardson (Chair and Chief Innovation Officer, Mte…
…
continue reading
1
Specialised Commissioning in the NHS – What do you need to know now
1:00:34
1:00:34
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:34
The proposed new NHSE systems for specialised commissioning are arguably the highest risk of all current dynamics, both for the NHS and for suppliers. Key aspects or policy have been published in ways that are hard to access and even harder to interpret. Here, we gather an expert panel to discuss what proposed new NHSE systems for specialised commi…
…
continue reading
1
اپیزود سیزدهم - چطوری تو موقعیت های اجتماعی اضطراب کمتری داشته باشیم
11:48
11:48
Spela senare
Spela senare
Listor
Gilla
Gillad
11:48
.اگر از اپیزود خوشتون اومده با ما در ارتباط باشین و ایمیل بزنین Email : mtechpodcast@gmail.com تبلیغ و اسپانسر نداریم و علاقمون، یادگیری و اضافه کردن ارزش به شما بهمون انرژی میده، پس دنبالمون کنید، ایمیل بزنید و ما رو به دوستاتون معرفی کنید. دوستون داریم
…
continue reading
تقدیم به مردم عزیز بلوچ سرزمینمون ایران
…
continue reading
1
Why are we waiting? - Pressures facing the NHS and how to deliver change
1:00:47
1:00:47
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:47
With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovat…
…
continue reading
1
اپیزود یازدهم - ابزار های تکنولوژی برای مدیریت زندگی / دایره طلایی از سایمون سینک
54:54
54:54
Spela senare
Spela senare
Listor
Gilla
Gillad
54:54
تقدیم به نیکا شاکرمی و تمام مردم آزادی خواه ایران زن زندگی آزادی
…
continue reading
1
Priority setting in primary care - NHS insights
59:35
59:35
Spela senare
Spela senare
Listor
Gilla
Gillad
59:35
How is the NHS balancing competing challenges as we head through integration and towards winter? How are priorities set and what does system planning look like in primary care? Dr Alex Degan (Primary Care Medical Director, Devon Integrated Care System [ICS]) joins Tom Clarke (Director, Mtech Access) to explore all this and more. In this episode, we…
…
continue reading
1
اپیزود دهم -- چرا و چجوری با تکنولوژی سالم زندگی کنیم؟ / چگونه سیستم ایمنی بدن را در برابر ویروس کرونا بسازیم؟
59:13
59:13
Spela senare
Spela senare
Listor
Gilla
Gillad
59:13
...این اپیزود تقدیم به مهسا امینی و زنده نگه داشتن هرچه بیشتر یادش Mahsa Amini, RIP...
…
continue reading
1
لینکدین چیه؟ / چجوری هزار دلار درامد آنلاین داشته باشیم؟
44:42
44:42
Spela senare
Spela senare
Listor
Gilla
Gillad
44:42
تو قسمت تکنولوژی، امیر واسمون از لینکدین میگه و اینکه چجوری کار میکنه، به چه دردی میخوره علی تو قسمت موفقیت یک راه نسبتا ساده رو معرفی میکنه که باهاش میشه درامد آنلاین ساخت و اصطلاحا آب باریکه ای درست کنیم که بتونه خیلی جاها تو زندگی کمک خرجمون باشه تو چالش ها و لحظه های خوب. بهمون ایمیل بزنین یا پیام بدید تا بهمون حس شنیده شدن و انگیزه بیشتر واسه …
…
continue reading
1
Integrated Care Systems go live in the NHS - reflections after 3 weeks
1:00:21
1:00:21
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:21
On 1st July we saw the introduction of legislation for Integrated Care Systems (ICSs) in the NHS. In the weeks since, what has changed for healthcare leaders, practitioners and patients? What are the key priorities for NHS decision-makers and what is getting in the way of change? How can Pharma and Medtech support their NHS customers as they implem…
…
continue reading
1
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
1:00:46
1:00:46
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:46
What roles and responsibilities do Clinical Pharmacists have in the NHS? How can Pharma and Medtech engage Clinical Pharmacists, and how can industry best support these new decision-makers? Tom Clarke (Director, Mtech Access) explores all this and more with Tom Kallis (Senior Clinical Pharmacist, East Cornwall PCN). They explore the origins of the …
…
continue reading
1
اپیزود هشتم: نوع جدید هدف گذاری / اپلیکیشن های آموزش زبان Babbel, Italki, Memrise
47:25
47:25
Spela senare
Spela senare
Listor
Gilla
Gillad
47:25
تو قسمت موفقیت این هفته، علی از در مورد یک نوع جدید وخلاقانه هدف گذاری صحبت میکنه که بر اساس دو اصل مهم هست به اسم لذت و کنترل.یعنی وقتی هدف گذاری میکنیم، اول این سوال رو از خودمون بپرسیم که به جای این که تمرکز کنیم روی یک مقصد مشخص، چطوری میتونیم از مسیر لذت ببریم؟و سوال دوم اینه که چجوری این مسیر میتونه کاملا تو کنترل خودمون باشه، و چرا بهتره …
…
continue reading
1
اپیزود هفتم : دستیار رایتینگ گرامارلی (Grammarly) چیست ؟ لایف استایل زندگی فصلی (seasonality of life)
45:37
45:37
Spela senare
Spela senare
Listor
Gilla
Gillad
45:37
تو اینترو توضیح میدیم که چجوری با رسیدن به اپیزود هفت، وارد ۳۰٪ بالای پادکستای دنیا شدیم. تو قسمت موفقیت علی برامون یک لایف استایل خوشگل معرفی میکنه برای هماهنگ تر زندگی کردن با طبیعت. هماهنگ زندگی کردن با طبیعت یعنی تو هر فصل سال ما سبک زندگی و تم و اولویت هامون عوض میشه. تو زمستون بهتر رو یادگیری تمركز کنیم، بهار فصل تجربه های جديد وصحیح و خطاست…
…
continue reading
1
Transforming systems and care pathways for an integrated NHS
1:00:47
1:00:47
Spela senare
Spela senare
Listor
Gilla
Gillad
1:00:47
As the NHS takes steps towards a more integrated future, how are systems and care pathways transforming? How is change being implemented, and what does this look like in reality for local systems and populations? Tom Clarke (Director, Mtech Access) explores all this and more with Debbie Morgan, (Director of Service Improvement and Transformation, C…
…
continue reading
1
دستیار رایتینگ کویل بات (QuillBot) چیست ؟ مهم ترین مهارت اجتماعی (قسمت سوم)
37:18
37:18
Spela senare
Spela senare
Listor
Gilla
Gillad
37:18
تو این اپیزود در مورد قسمت سوم مهارت های اجتماعی صحبت میکنیم که چطوری با یک تکنیک به ایم بیپ-بیپ، ما میتونیم مکالمه رو به مسیری هدایت کنیم که دو طرف مکالمه لذت ببرن از ارتباط،تو قسمت تکنولوژی ،امیر واسامون از یک ابزار رایتینگمیگه به اسمکویل بات،که کمک میکنه متن های انگلیسیمون رو دوباره نویسی کنیم تا درگیر مسائلی مثل کپی رایت نشیم و همچنین تو بهتر…
…
continue reading
1
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
39:25
39:25
Spela senare
Spela senare
Listor
Gilla
Gillad
39:25
Our experts in health economics, value communication, design and digital discuss how to craft digital payer value communication tools to meet the needs of internal stakeholders, including market access teams and KAMs, and healthcare customers. What does a best-in-class value communication tool look like in 2022? What are the key considerations when…
…
continue reading
1
افیلیت مارکتینگ چیست؟ (Affiliate Marketing) / مهم ترین مهارت اجتماعی - قسمت دوم
35:11
35:11
Spela senare
Spela senare
Listor
Gilla
Gillad
35:11
تو قسمت موفقیت این اپیزود, میخوایم در مورد ۴ تا از اشتباه های رایج مکالمه هامون صحبت کنیم، این که چرا این اشتباه ها رو انجام میدیم، چجوری اتفاق میوفتن و چی هستن اصلا این اشتباه ها. تو بخش آخر هم سعی میکنیم چند تا راه حل عملی واسه کم شدن این اشتباه ها بگیم. و تو قسمت تکنولوژی هم در مورد affiliate marketing صحبت میکنیم که یک طرح کسب و کار جالب و آیند…
…
continue reading
1
(چت بات چیه ؟ / مهم ترین مهارت اجتماعی (قسمت اول (Chatbot)
32:35
32:35
Spela senare
Spela senare
Listor
Gilla
Gillad
32:35
چرا از چت بات استفاده بکنیم؟-چون سرعت میره بالا-هزینه ها پایین میاد-یک کارمند ۲۴ ساعته آماده پاسخویی دارین-آمارنشون میده مشتری ها نسبتا کار باهاش رو دوس دارن-ساختنش راحته و احتیاج به دونستن زبون برنامه نویسی ندارهچت بات چیه و چطوری کار میکنه؟-امیر توضیح میده چجوری و کجا ها چت بات ها به درد میخورن مثل سایت هایی که با کاربر زیاد سر و کار دارن و میخوا…
…
continue reading
1
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
56:04
56:04
Spela senare
Spela senare
Listor
Gilla
Gillad
56:04
What does population health management mean for the NHS, for patients, and for industry? How will the NHS translate population health management into impactful service change and what will this look like for patients? Tom Clarke (Director, Mtech Access) explores all this and more with guest speaker Dr Steven Laitner (GP, Parkbury House Surgery). St…
…
continue reading
1
نتورکینگ(Networking) چیه و چجوریه؟ اپلیکیشن کلاب هوس (Clubhouse) چیه؟
38:11
38:11
Spela senare
Spela senare
Listor
Gilla
Gillad
38:11
تو این اپیزود میگیم چرا، چجوری نتورک کنیم و محصول نتورک کردن چیه؟ تو قسمت چرا، علی توضیح میده نتورک فقط برای کار نیست و برای تبادل اطلاعات تو زمینه علاقه هامون هم میتونیم ارتباط برقرار کنیم با آدم ها و تاثیر خوبشو تو زندگیمون ببینیم. تو قسمت چجوری، امیر اومده که اپلیکیشن کلاب هوس رو معرفی کنه که جدید هم هست و جای مناسبیه واسه پیدا کردن آدم های هم…
…
continue reading